SRDAPRT

Sarda Proteins financials

Market cap
₹80 Cr

Quarterly results

Q1 FY27: revenue up 18.6%, net profit up 438.8% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue0 24 0 11 4 +2971%0 −99%1 13 +19%
EBITDA0 0 -0 -0 0 +164%-0 −220%1 +700%-3 −567%
Net profit0 0 -0 -0 0 +264%-0 −220%1 +864%2 +439%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −21.8% 1Y

₹60₹80₹100₹120₹140Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Aug 26

1Y: ₹137.1 on 8 Sept 2025 → ₹107.25. High ₹137.1 (8 Sept 2025), low ₹63.06 (20 Nov 2025).

Financials, as filed

Revenue grew 252.5% a year over 2 years, FY24 to FY26. Operating margin widened to 1.7%.

Year endingFY24FY25FY26
Revenue₹1 Cr₹24 Cr₹16 Cr
Operating profit₹-0 Cr₹0 Cr₹0 Cr
Operating margin-10.8%0.1%1.7%
Interest₹0 Cr₹0 Cr₹0 Cr
Depreciation₹0 Cr₹0 Cr₹0 Cr
Net profit₹0 Cr₹0 Cr₹1 Cr
Net margin1.5%0.1%3.9%
Cash from operations₹-0 Cr₹-0 Cr₹-76 Cr
Free cash flow₹-0 Cr₹-0 Cr₹-76 Cr
ROCE0.8%0.8%23.1%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr
Reserves₹-0 Cr₹-0 Cr₹-0 Cr₹-0 Cr₹-0 Cr₹1 Cr
Borrowings₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Other liabilities₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹85 Cr₹83 Cr
Total liabilities₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹87 Cr₹87 Cr
Fixed assets₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Capital work in progress₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Investments₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Other assets₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹87 Cr₹87 Cr
Total assets₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹87 Cr₹87 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, promoters added +80.66 pp while the public trimmed −80.66 pp. The shareholder count shrank 1% to 2,897.

Promoters
80.7%
Public
19.3%

Since Jun 2025

  • Promoters +80.66 pp
  • Public −80.66 pp

How it drifted, 12 quarters

Over this window promoters went from 28.4% to 80.7% — +52.2 pp.

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 28.4%, Public 71.6%.Dec '23: Promoters 28.4%, Public 71.6%.Mar '24: Promoters 28.4%, Public 71.6%.Jun '24: Public 100.0%.Sep '24: Public 100.0%.Dec '24: Public 100.0%.Mar '25: Public 100.0%.Jun '25: Public 100.0%.Sep '25: Public 100.0%.Dec '25: Public 100.0%.Mar '26: Public 100.0%.Jun '26: Promoters 80.7%, Public 19.3%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 0 holders trimming and 14 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of Sarda Proteins Ltd above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Onix Renewable Limited 78.24%newly disclosed
Divyeshkumar Mansukhlal Savaliya 1.31%newly disclosed
Savaliya Piyushkumar Mansukhbhai 1.11%newly disclosed
Guttikonda Vara Lakshmi —off the list
Manoj Kumar Kanda —off the list
Uday R Shah (Huf) —off the list
Ruchira Goyal - 2 —off the list
Neelima Karlapudi —off the list
Kanta Devi Samdaria —off the list
Jainam Uday Shah —off the list
Rajasekhar Guttikonda —off the list
Kartik Bathla —off the list

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Learn to analyse Sarda Proteins Ltd

Guides on how to read this kind of business and the numbers that matter.